BioNxt Solutions Inc.
VANCOUVER, BC / ACCESSWIRE / July 17, 2024 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT) is pleased to report that it has signed a statement of work ("SOW") with a German-based international contract research, development, and manufacturing organization (the "CRDMO"). The SOW is focused on the Company's flagship Cladribine oral dissolvable film ("ODF") development program.
The SOW sets out a number of important deliverables, including but not limited to technology transfer and implementation, evaluation batch production (GMP material under GMP conditions), stability testing, cGMP manufacturing of clinical study samples, and preparation of the PK study Investigational Medical Product Dossier for EU submission.
BioNxt is developing a 100% owned and proprietary ODF Cladribine dosage form, directed at the multiple sclerosis ("MS") market. Cladribine tablets are currently approved for use in over 75 countries, including by the United States Food and Drug Administration ("FDA") and the European Medicines Agency ("EMA"), with annual sales in excess of one billion USD. Cladribine tablets are approved for several indications, namely highly active forms of relapsing-remitting MS and certain forms of leukemia. MS represents the largest market segment for the sale of Cladribine with approximately 2.3 million people living with MS worldwide, with the highest prevalence in North America and Europe, noted by Atlas of MS. The global Multiple Sclerosis drug market is expected to top USD 41 billion by 2033 according to Market.us.
The CRDMO has a head office in Munich, Germany, with an international network of pharmaceutical service providers with facilities in five countries and over 500 employees. They offer GCP/GLP/GMP/ISO/IEC-certified services and GMP certified manufacturing of clinical trial supplies (Phase I-III) with a specialization in solids, semi-solids, liquids, oral films, and transdermal patches as well as integrated lab analytical services during development & GMP manufacturing, including API characterization, method development, optimization, validation, permeation studies, stabilities studies, etc.
The Company has filed Cladribine ODF-related provisional patent applications with three to four patent applications expected to be on file in major international jurisdictions by late 2024 to early 2025 with potential patent protection extending to 2044.
About BioNxt Solutions Inc.
BioNxt Solutions Inc. is a bioscience accelerator focused on next-generation drug formulations and delivery systems, diagnostic screening tests, and new active pharmaceutical production and evaluation, including: precision transdermal and oral dissolvable drug formulations; rapid, low-cost infectious disease and oral health screening tests; and standardization and clinical evaluation of emerging active pharmaceutical ingredients for neurological applications. The Company has research and development operations in North America and Europe, with an operational focus in Germany, and is currently focused on regulatory approval and commercialization of medical products for European markets.
BioNxt Solutions Inc.
Wolfgang Probst, CEO and Director
Email: info@bionxt.com
Phone: +1 780-818-6422
Cautionary Statement Regarding "Forward-Looking" Information
Some of the statements contained in this news release are forward-looking statements and information within the meaning of applicable securities laws. Forward-looking statements and information can be identified by the use of words such as "expects", "intends", "is expected", "potential", "suggests" or variations of such words or phrases, or statements that certain actions, events or results "may", "could", "should", "would", "might" or "will" be taken, occur or be achieved. Forward-looking statements and information are not historical facts and are subject to a number of risks and uncertainties beyond the Company's control. Actual results and developments are likely to differ, and may differ materially, from those expressed or implied by the forward-looking statements contained in this news release. Accordingly, readers should not place undue reliance on forward-looking statements. The Company undertakes no obligation to update publicly or otherwise revise any forward-looking statements, except as may be required by law.
SOURCE: BioNxt Solutions Inc.
View the original press release on accesswire.com
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
FINOS Launches Fluxnova with Fidelity Investments, NatWest Group, Deutsche Bank and Capital One - An Open Source Orchestration Platform to Scale Process Automation21.10.2025 18:00:00 CEST | Press release
Announced at the Open Source in Finance Forum (OSFF), Fluxnova empowers financial institutions to modernize their infrastructure, reduce vendor dependency, and build long-term industry resilience. NEW YORK CITY, NY / ACCESS Newswire / October 21, 2025 / The Fintech Open Source Foundation (FINOS), the foundation of open innovation in financial services, today announced the launch of Fluxnova, an open orchestration platform developed in partnership with Fidelity Investments, NatWest Group, Deutsche Bank, and Capital One. Fluxnova delivers audit-ready workflows at scale, helping institutions visualize and automate their processes. By doing so, companies are better positioned to modernize operations and maintain strong governance across their processes. Fluxnova offers developers a toolkit for designing and deploying Business Process Model and Notation (BPMN) and Decision Model and Notation (DMN) models with a high-performance engine to execute and trace workflows. Business teams gain tran
Foundry Welcomes Gregory Anderson as Global Chief Revenue Officer21.10.2025 15:00:00 CEST | Press release
Global Sales Leader to Drive Unified Strategy and Accelerate Customer-Centric Growth NEW YORK CITY, NY / ACCESS Newswire / October 21, 2025 / Foundry, the leading global tech media, data, and marketing services company, is thrilled to announce the appointment of Gregory Anderson as Global Chief Revenue Officer (CRO). With two decades of proven success driving sales performance across technology and media sectors, Anderson joins Foundry with a clear focus on enhancing the buyer journey and accelerating strategic growth globally. Anderson joins Foundry from Informa TechTarget, where he most recently served as Chief Sales Officer at Omdia. During his tenure, he held several other key leadership roles, including positions leading sales and the integration of major acquisitions such as BrightTALK and Enterprise Strategy Group (ESG). He also spent eight years as VP of Sales for APAC at Informa TechTarget, where he helped expand regional operations. "We are thrilled to welcome Greg to the Fou
Air T Enters into Agreement with Regional Express Holdings Limited21.10.2025 12:00:00 CEST | Press release
MINNEAPOLIS, MINNESOTA / ACCESS Newswire / October 21, 2025 / Air T, Inc. (NASDAQ:AIRT) has entered into a Sale and Implementation Deed (SID) with the Administrators of Regional Express Holdings Limited (Administrators Appointed) and certain of its subsidiaries (Rex), which operates the leading regional airline in Australia. Air T expects to close the acquisition of Rex by year-end if creditor and other approvals are obtained. Air T has been working closely with the Administrators and the Australian Government, Rex's secured lender, to develop a solution that best serves the interests of all stakeholders. To support the implementation of the acquisition, Air T and the Commonwealth of Australia have entered into an agreement pursuant to which Rex's financing arrangements will be restructured in connection with the acquisition. The proposed acquisition contemplates a continuation and growth of Rex's regional airline business and continuing employment for its workforce. Rex plays an essen
Ubiquity Strengthens European Leadership with Appointment of Megan Porter as EVP, UK & Europe21.10.2025 09:00:00 CEST | Press release
Appointment underscores Ubiquity's continued investment in Europe, expanding onshore and offshore CX delivery to support global clients with scalable, multilingual solutions. LONDON, GB / ACCESS Newswire / October 21, 2025 / Ubiquity, a global provider of customer experience (CX) and business process outsourcing (BPO) solutions, today announced the appointment of Megan Porter as Executive Vice President, UK & Europe. In her new role, Porter will lead regional growth efforts, build local partnerships, and represent Ubiquity's expanding presence across the UK and wider European markets. The appointment comes as Ubiquity continues to accelerate its investment in the region with the opening of its Sheffield, UK delivery centre, expanding capacity to support onshore programmes for fintech, healthcare, insurance, and e-commerce clients. This expansion complements Ubiquity's nearshore and offshore capabilities across Accra, Ghana, and Eastern Europe, providing flexible, multilingual support t
Clean Air Metals Drilling Confirms Down-Plunge Extension of the Escape Deposit20.10.2025 13:00:00 CEST | Press release
THUNDER BAY, ON / ACCESS Newswire / October 20, 2025 / Clean Air Metals Inc. ("Clean Air Metals" or the "Company") (TSX.V:AIR)(FRA:CKU)(OTCQB:CLRMF) is pleased to announce that its 2025 summer drilling program at the Company's 100%-owned Thunder Bay North Critical Minerals Project ("TBN") has confirmed the continuation of the Escape Deposit into a previously untested 2.5 km long magnetic anomaly that connects to the known mineral resources. The single hole completed during this program intersected high-tenor sulphide mineralization having comparable thickness and metal grades to the existing Escape Deposit resource. Given its significant size, the Escape down-plunge target represents the highest potential resource addition opportunity for the TBN project. Assay highlights from hole EL25-001: 53 m of 0.52 g/t Pt, 0.69 g/t Pd, 0.26% Cu and 0.17% Ni(from 404 m downhole, including 0.84 g/t Pt, 1.12 g/t Pd, 0.41% Cu and 021% Ni over 22 m from 411 m, and 1.08 g/t Pt, 1.41 g/t Pd, 0.52% Cu an
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom